Literature DB >> 23621407

Multifunctional dendritic sialopolymersomes as potential antiviral agents: their lectin binding and drug release properties.

Ali Nazemi1, S M Mansour Haeryfar, Elizabeth R Gillies.   

Abstract

Polymer vesicles, commonly referred to as polymersomes, are self-organized materials that result from the self-assembly of amphiphilic copolymers in solution. Recently, there has been increasing interest in biomedical applications of polymersomes due to the different functions that can be imparted through encapsulation of molecules within the core or membrane or through the introduction of bioactive molecules to the polymersome surface. We describe here the development and study of poly(ethylene oxide)-polycaprolactone polymersomes designed to interact with influenza viruses at two different stages in the infection process. First, the conjugation of the sialic acid N-acetylneuraminic acid (Neu5Ac) to the polymersome surface was designed to inhibit the binding of viral hemagglutinin to sialic acids on host cells, thus preventing viral entry. Second, the incorporation of the neuraminidase inhibitor zanamivir into the polymersome core was designed to prevent the release of progeny virus from the host cells, thus inhibiting viral replication. With the aim of maximizing multivalent effects at the polymersome surface, polyester dendrons functionalized with Neu5Ac were synthesized and conjugated to polymersomes. Binding of the resulting dendritic sialopolymersomes to Limax flavus agglutinin was studied and compared to the sialodendron and a monovalent Neu5Ac derivative using an enzyme-linked lectin inhibition assay. It was found that while the sialodendron exhibited a 17-fold enhancement (per sialoside) relative to the small molecule, the dendritic sialopolymersomes resulted in an almost 2000-fold enhancement in binding affinity. It was also demonstrated that encapsulation of zanamivir into the dendritic sialopolymersomes could be performed with the same efficiency as for naked polymersomes to provide a drug loading of ~35 wt %. Drug release rates were similar for both systems with sustained release over a period of 4 days. Overall, these results suggest the promise of using a multifunctional polymersome system for interaction with and inhibition of influenza viruses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23621407     DOI: 10.1021/la400890f

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  7 in total

Review 1.  Advances in nanotechnology application in biosafety materials: a crucial response to COVID-19 pandemic.

Authors:  Rasmi V Morajkar; Akhil S Kumar; Rohan K Kunkalekar; Amit A Vernekar
Journal:  Biosaf Health       Date:  2022-06-24

Review 2.  Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes.

Authors:  Erika Dosekova; Jaroslav Filip; Tomas Bertok; Peter Both; Peter Kasak; Jan Tkac
Journal:  Med Res Rev       Date:  2016-11-15       Impact factor: 12.944

3.  A carbohydrate-grafted nanovesicle with activatable optical and acoustic contrasts for dual modality high performance tumor imaging.

Authors:  Xuanjun Wu; Bijuan Lin; Mingzhu Yu; Liu Yang; Jiahuai Han; Shoufa Han
Journal:  Chem Sci       Date:  2014-12-22       Impact factor: 9.825

4.  Multivalent Peptide-Nanoparticle Conjugates for Influenza-Virus Inhibition.

Authors:  Daniel Lauster; Maria Glanz; Markus Bardua; Kai Ludwig; Markus Hellmund; Ute Hoffmann; Alf Hamann; Christoph Böttcher; Rainer Haag; Christian P R Hackenberger; Andreas Herrmann
Journal:  Angew Chem Int Ed Engl       Date:  2017-04-26       Impact factor: 15.336

5.  Structure-Activity Relationships of GAG Mimetic-Functionalized Mesoporous Silica Nanoparticles and Evaluation of Acyclovir-Loaded Antiviral Nanoparticles with Dual Mechanisms of Action.

Authors:  Edward C Lee; Chau T H Nguyen; Ekaterina Strounina; Nicholas Davis-Poynter; Benjamin P Ross
Journal:  ACS Omega       Date:  2018-02-09

Review 6.  Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years.

Authors:  Hanadi Sinokrot; Tasneem Smerat; Anas Najjar; Rafik Karaman
Journal:  Molecules       Date:  2017-10-16       Impact factor: 4.411

Review 7.  Nanotechnology for virus treatment.

Authors:  Jiarong Zhou; Nishta Krishnan; Yao Jiang; Ronnie H Fang; Liangfang Zhang
Journal:  Nano Today       Date:  2020-12-01       Impact factor: 20.722

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.